Previous SARS-CoV-2 Infection Status Among the Current RT-PCR-Positive Individuals Affected During the Second Wave of COVID-19 Infections in Chennai, India인도 첸나이에서 COVID-19 감염의 두 번째 물결 동안 영향을 받은 현재 RT-PCR-양성 개인 중 이전 SARS-CoV-2 감염 상태Article Published on 2022-04-042022-09-11 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] 95% CI antibodies antibody Asymptomatic asymptomatic individual Chennai Contact contact with coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 case COVID-19 patient current diagnosed genomic genomic sequencing IgG IgG antibodies IgG antibody IgM Immunity Immunoglobulin Immunoglobulin G India indication individual individuals positive positive individuals ranged Re-infection Re-infections reactive Reinfection reinfection. SARS-CoV-2 second second wave Seropositivity status symptom onset tested variants of concern Wave [DOI] 10.3389/fpubh.2022.836454 PMC 바로가기 [Article Type] Article
Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters1차 SARS-CoV-2 감염의 보호 면역은 시리아 햄스터의 델타 변종으로 재감염 후 질병 심각도를 감소시킵니다Article Published on 2022-03-132022-09-11 Journal: Viruses [Category] SARS, 변종, [키워드] acute respiratory syndrome AY.1 B.1 caused Characteristics characterized coronavirus disease Coronavirus disease 2019 Delta Delta AY.1 delta variant disease disease severity dominant dose Evidence evidence of groups hamster hamsters high viral load Immunity Infection initial interstitial pneumonia K417N K417N mutation lineages Lung disease Mild Mild disease neutralization Neutralizing neutralizing antibody pathogenicity produced re-infected Re-infection re-infection. Re-infections reduce reduced reduction in Reinfection remained respiratory respiratory tract SARS-CoV-2 SARS-CoV-2 lineage Severe acute respiratory syndrome severe acute respiratory syndrome coronavirus-2 sterilizing immunity Syrian hamsters the disease upper upper respiratory tract variant variants Viral load viral RNA load virus [DOI] 10.3390/v14030596 PMC 바로가기 [Article Type] Article
SARS-CoV-2: Emergence of New Variants and Effectiveness of VaccinesSARS-CoV-2: 새로운 변이체의 출현과 백신의 효과Review Published on 2021-12-142022-09-11 Journal: Frontiers in Cellular and Infection Microbiology [Category] SARS, 변종, 진단, [키워드] administration antigenic clinical evaluation company conditions Diseases domain effective Effectiveness Efficacy emergence Epitopes glycoprotein Hospitalization Human Immunity Infection Infectivity Mortality neutralization neutralize Neutralizing antibodies New pandemic Re-infection Re-infections S glycoprotein SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines SARS-CoV-2 variant SARS-CoV-2 variants spike the vaccine the vaccines Transmissibility Vaccine Vaccine development Vaccines variant variants of SARS-CoV-2 [DOI] 10.3389/fcimb.2021.777212 PMC 바로가기 [Article Type] Review
SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccinesSARS-CoV-2 새로운 변종: 특징적인 특징과 다양한 백신의 효능에 미치는 영향Review Published on 2021-11-012022-09-11 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition coronavirus country creating declined effective Efficacy effort evade explained feature Health Hospitalization immune response Infectivity mortality rate New New Variants Pathogenesis Re-infection Re-infections Reinfection reported risk SARS-CoV-2 severe acute respiratory syndrome Coronavirus the vaccine therapeutic therapeutic strategy Therapeutics Transmission triggered Vaccine vaccine. variant variants variants of SARS-CoV-2 [DOI] 10.1016/j.biopha.2021.112176 PMC 바로가기 [Article Type] Review
The Long-Term Characteristics of Immunity Conferred by COVID-19 Using Antibody TestsInternal Medicine Published on 2021-09-052022-10-31 Journal: Cureus [Category] COVID-19, [키워드] age anti-sars cov2 antibody anti-SARS-CoV-2 antibody anti-SARS-CoV-2 antibody test antibody Antibody Response association CAD Care Chronic kidney disease co-morbidities co-morbidity comorbities confirmed cases Coronary artery disease COVID-19 COVID-19 virus death Diabetes Mellitus dialysis disease Efficacy End-stage renal disease ESRD Gender General population HCW Health healthcare worker Healthcare workers high risk hypertension Immunity male malignancies malignancy natural immune response nosocomial COVID-19 nucleocapsid antigen objective Patient patients patients with haematological PCR persistence polymerase chain Population positive positive antibody response PROTECT Protective Protein Radiotherapy re-infected Re-infection Re-infections reactive Reinfection reported Result risk severe disease Sex Significant Symptom Symptoms Test the mean the patient [DOI] 10.7759/cureus.17731 PMC 바로가기 [Article Type] Internal Medicine
Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infectionSARS-CoV-2 감염 후 14개월 동안 항체 반응에 대한 종단 관찰Observational Study Published on 2021-09-012022-09-11 Journal: Clinical immunology (Orlando, Fla.) [Category] SARS, 임상, 진단, 치료법, [키워드] Analysis analyzed anti-S Anti-spike Antibody assays Antibody Response Antibody responses Antibody titer Antibody titers Better binding domain carried Clinical course clinical history coronavirus COVID19 demographics different time points false-negative rate highlight Humoral immunity IgG IgG antibody IgG antibody titer IgG antibody titers immunoassay immunoassays implementation Italy Longevity longitudinal longitudinal analysis Loss of Smell loss of smell and taste magnitude natural infection Neutralizing antibodies neutralizing antibodies. observation positive Protein RBD IgG Re-infection Re-infections recovered COVID-19 patient recovered patients S-RBD SARS-CoV-2 SARS-COV-2 infection serological test Serological tests seronegative significantly higher subject Symptom Taste tested the disease vaccination were used [DOI] 10.1016/j.clim.2021.108814 PMC 바로가기 [Article Type] Observational Study
SARS-CoV-2 antibody response dynamics and heterogeneous diagnostic performance of four serological tests and a neutralization test in symptomatic healthcare workers with non-severe COVID-19중증이 아닌 COVID-19를 가진 증상이 있는 의료 종사자를 대상으로 한 4가지 혈청 검사 및 중화 검사의 SARS-CoV-2 항체 반응 역학 및 이종 진단 성능Observational Study Published on 2021-08-012022-09-11 Journal: Journal of Clinical Virology [Category] MERS, SARS, 임상, 진단, 치료기술, [키워드] aims antibody Antibody Response Bio-rad Chain Reaction COVID-19 COVID-19 patient detectable detection rate diagnostic diagnostic test ELISA ELISAs enzyme-linked immunosorbent assay enzyme-linked immunosorbent assays Euroimmun evaluated Genscript HCW HCWs healthcare worker Healthcare workers heterogeneous heterogenous highest hospital infected individuals Infection initial moment MOST neutralization neutralization test Neutralizing observational study PCR PCR-confirmed polymerase chain polymerase chain reaction positive presence of antibody prospective observational study Re-infection Re-infections remained SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 infected individuals SARS-COV-2 infection serological test serology Serology. seropositive serum serum sample serum samples study inclusion surrogate virus neutralization test sVNT symptomatic symptomatic individual the antibody response Variability virus neutralization test was performed [DOI] 10.1016/j.jcv.2021.104904 PMC 바로가기 [Article Type] Observational Study
A tale of two diseases: Sarcoidosis, COVID-19 and new therapeutic options with dual RAS inhibition and tetanus-diphtheria vaccineResearch article Published on 2021-07-012022-10-05 Journal: Medical Hypotheses [Category] SARS, 치료제, [키워드] ACE2 ACE2 binding Anergy angiotensin antibodies antigenic Antiviral agents ARDS beta coronavirus CD4+ CD4+ T cell CD8+ T cell Cell Combination COVID-19 described dysfunction Hydroxychloroquine immune dysregulation immune response lung Mortality natural killer overcome pathogen problem RAS RAS inhibition Re-infections receptor renin-angiotensin system response responsible sarcoidosis SARS CoV-2 similarity target Tetanus-diphtheria vaccine the disease the patient therapeutic option therapeutic strategy turn Vaccine [DOI] 10.1016/j.mehy.2021.110619 [Article Type] Research article
A human coronavirus evolves antigenically to escape antibody immunity인간 코로나 바이러스는 항체 면역을 피하기 위해 항원 적으로 진화합니다.Research Article Published on 2021-04-082022-08-13 Journal: PLoS Pathogens [Category] Biology and Life Sciences, COVID-19, SARS, [키워드] 229E 229E strain 229E strains 229E viral strain 229E viruses accumulate anti-SARS-CoV-2 titer anti-SARS-CoV-2 titers antibody antibody immunity antigenic evolution common-cold comparable coronavirus coronavirus coronavirus 229E coronavirus vaccine Coronavirus vaccines Coronaviruses degrade elicited Evolution Hope Human coronavirus human coronavirus 229E human sera Hypothesis identify Immunity in some individuals Infection less Mutation neutralization neutralize Neutralizing titer neutralizing titers NTD occur Older other coronaviruses pace PROTECT question re-infect Re-infection Re-infections Receptor-binding domain Region SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccines seasonal coronavirus sera Spike protein strain Strains subsequent the RBD the receptor-binding domain titers vaccination variants of SARS-CoV-2 Viral viral evolution viral mutation Viral mutations viral spike viral strains virus virus viruses was collected [DOI] 10.1371/journal.ppat.1009453 PMC 바로가기 [Article Type] Research Article
Main differences between the first and second waves of COVID-19 in Madrid, Spain스페인 마드리드의 COVID-19 1차와 2차의 주요 차이점Article Published on 2021-04-012022-09-12 Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 진단, [키워드] activity acute respiratory syndrome addition antibodies Antigen capillary blood Christma clinical symptom clinically collected commenced contributed coronavirus Coronavirus-2 COVID-19 cumulative Face masks First wave greater Health services individual information less lockdown measure occurred oral swab pandemic pathogenicity polymerase chain positive Prevalence proportion Rapid diagnostic test Re-infection Re-infections Saliva SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 antigen SARS-CoV-2-specific antibody SARS-CoV-2. second wave seroreversion social distancing Spain Spread tested viral inoculum [DOI] 10.1016/j.ijid.2021.02.115 PMC 바로가기 [Article Type] Article